News Medical on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...
Andre Esteva, PhD, is an AI scientist, entrepreneur, and CEO of ArteraAI, revolutionizing cancer therapy through personalized diagnostics. A globally recognized ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...
Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...
More than 370,000 insured patients in the US underwent kidney stone surgery in 2019, highlighting the importance of the 2026 AUA guidelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback